Novel ester derivatives of buprenorphine and their preparation processes, and long acting analgestic pharmaceutical compositions

Inactive Publication Date: 2005-04-07
CHI MEI MEDICAL CENT
View PDF4 Cites 52 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0018] Therefore, an object of this invention is to provide novel ester derivatives of buprenorphine which have a longer duration of action an

Problems solved by technology

Local anesthetics, e.g., xylocaine or bupivacaine, relieve some types of pain but they can only be applied to restricted areas.
In addition, local anesthetics are short-acting and exhibit a duration of action normally no more than 6 hours even when introduced intrathecally.
Therefore, local anesthetics are not satisfactory for the relief of acute and severe pain caused by cardiac, pulmonary, abdominal, orthopedic and obstetrical surgery, severe burn injury, and terminal stage of cancer.
Weak analgesics, such as acetaminophen and nonsteroidal anti-inflammatory agents (NSAID), relieve pain of only low intensity, such as pain due to headache or toothache, but they do not help in the case of severe pain.
However, all the opioid analgesics exhibit common disadvantages (Hayes, A. G. et al., Br. J. Pharmacol., Vol 79, 731, 1983).
The most unwanted problem associated with the long-term use of these potent analgesics is the incidence of addiction.
In addition, these potent analgesics may induce severe respiratory depression in patients with poor respiratory function.
Moreover, these potent analgesics exhibit a r

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel ester derivatives of buprenorphine and their preparation processes, and long acting analgestic pharmaceutical compositions
  • Novel ester derivatives of buprenorphine and their preparation processes, and long acting analgestic pharmaceutical compositions
  • Novel ester derivatives of buprenorphine and their preparation processes, and long acting analgestic pharmaceutical compositions

Examples

Experimental program
Comparison scheme
Effect test

examples

[0108] The following examples are given for the purpose of illustration only and are not intended to limit the scope of the present invention.

[0109] The following Table 1 shows the chemical structures of the preferred buprenorphine ester derivatives according to this invention

TABLE 1The molecular structures of buprenorphine HCl,buprenorphine base and the ester derivativesof according to this inventionCompoundMolecular structureBuprenorphine HClBup · HClBuprenorphine baseBupBuprenorphine propionateBuprenorphine pivalateBuprenorphine benzoateBuprenorphine enanthateBuprenorphine decanoateBuprenorphine palimitateDibuprenorphine pimelateDibuprenorphine sebacoyl ester

Bup: Buprenorphine

The buprenorphine ester derivatives listed in Table 1 can be synthesized by suitable known methods, such as those disclosed in U.S. Pat. Nos. 5,750,534 and 6,225,321.

Synthesis Ex. 1

Preparation of Buprenorphine Enanthate

[0110] 75 mL of methylene chloride (Mallinckrodt, Baker, U.S.A.) and 0.01 mole of bupr

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Temperatureaaaaaaaaaa
Temperatureaaaaaaaaaa
Lengthaaaaaaaaaa
Login to view more

Abstract

Disclosed herein are novel buprenorphine monocarboxylic ester derivatives and dibuprenorphine dicarboxylic ester derivatives which exert a longer analgesic effect as compared to buprenorphine hydrochloride. Also disclosed are the processes for synthesizing the novel ester derivatives of buprenorphine, and long-acting analgesic pharmaceutical compositions containing a compound selected from buprenorphine base and the novel ester derivatives of buprenorphine.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner CHI MEI MEDICAL CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products